UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing

The New England journal of medicine, 2004-08, Vol.351 (8), p.760-768

2004

Volltextzugriff (PDF)

Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates

Journal of Clinical Microbiology, 2008-02, Vol.46 (2), p.499-506

2008

Volltextzugriff (PDF)

Genetic variability of West Nile virus in US blood donors, 2002-2005

Emerging infectious diseases, 2008-03, Vol.14 (3), p.436-444

2008

Volltextzugriff (PDF)

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

Transfusion (Philadelphia, Pa.), 2005-02, Vol.45 (2), p.254-264

2005

Volltextzugriff (PDF)

Chagas disease and the US blood supply

Current opinion in infectious diseases, 2008-10, Vol.21 (5), p.476-482

2008

Volltextzugriff (PDF)

Screening the Blood Supply for West Nile Virus RNA by Nucleic Acid Amplification Testing

The New England journal of medicine, 2005-08, Vol.353 (5), p.460-467

2005

Volltextzugriff (PDF)

Virus and Antibody Dynamics in Acute West Nile Virus Infection

The Journal of infectious diseases, 2008-10, Vol.198 (7), p.984-993

2008

Volltextzugriff (PDF)

Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi

Transfusion (Philadelphia, Pa.), 2012-09, Vol.52 (9), p.1901-1911

2012

Volltextzugriff (PDF)

Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay

Transfusion (Philadelphia, Pa.), 2014-09, Vol.54 (9), p.2237-2244

2014

Volltextzugriff (PDF)

Determination of B abesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay

Transfusion (Philadelphia, Pa.), 2014-09, Vol.54 (9), p.2237-2244

2014

Volltextzugriff (PDF)

Transfusion-associated transmission of West Nile virus, United States 2003 through 2005

Transfusion (Philadelphia, Pa.), 2006-12, Vol.46 (12), p.2038-2046

2006

Volltextzugriff (PDF)

Phylogenetic analysis of WNV in North American blood donors during the 2003–2004 epidemic seasons

Virology (New York, N.Y.), 2007-06, Vol.363 (1), p.220-228

2007

Volltextzugriff (PDF)

NAT of the United States and Canadian blood supply

Transfusion (Philadelphia, Pa.), 2000-10, Vol.40 (10), p.1165-1168

2000

Volltextzugriff (PDF)

West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing

Transfusion (Philadelphia, Pa.), 2009-06, Vol.49 (6), p.1160-1170

2009

Volltextzugriff (PDF)

Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: Analysis of 2003 data to inform 2004 decision making

Transfusion (Philadelphia, Pa.), 2004-11, Vol.44 (11), p.1547-1554

2004

Volltextzugriff (PDF)

Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms

Transfusion (Philadelphia, Pa.), 2006-05, Vol.46 (5), p.695-702

2006

Volltextzugriff (PDF)

TRANSFUSION COMPLICATIONS: Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms

Transfusion (Philadelphia, Pa.), 2006-05, Vol.46 (5), p.695-702

2006

Volltextzugriff (PDF)

Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA

Transfusion (Philadelphia, Pa.), 2002-07, Vol.42 (7), p.876-885

2002

Volltextzugriff (PDF)

Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV-1 and HCV assay

Transfusion (Philadelphia, Pa.), 2004-01, Vol.44 (1), p.91-96

2004

Volltextzugriff (PDF)

TRANSFUSION COMPLICATIONS: Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: Analysis of 2003 data to inform 2004 decision making

Transfusion (Philadelphia, Pa.), 2004-11, Vol.44 (11), p.1547-1554

2004

Volltextzugriff (PDF)

TRANSFUSION COMPLICATIONS: A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

Transfusion (Philadelphia, Pa.), 2005-02, Vol.45 (2), p.254-264

2005

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)
Japanisch
(2)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing

Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates

Genetic variability of West Nile virus in US blood donors, 2002-2005

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

Chagas disease and the US blood supply

Screening the Blood Supply for West Nile Virus RNA by Nucleic Acid Amplification Testing

Virus and Antibody Dynamics in Acute West Nile Virus Infection

Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi

Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay

Determination of B abesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay

Transfusion-associated transmission of West Nile virus, United States 2003 through 2005

Phylogenetic analysis of WNV in North American blood donors during the 2003–2004 epidemic seasons

NAT of the United States and Canadian blood supply

West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing

Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: Analysis of 2003 data to inform 2004 decision making

Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms

TRANSFUSION COMPLICATIONS: Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms

Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA

Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV-1 and HCV assay

TRANSFUSION COMPLICATIONS: Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: Analysis of 2003 data to inform 2004 decision making

TRANSFUSION COMPLICATIONS: A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

Suchergebnisse filtern